Insulin Lispro Injection, Solution
Product Images NDC 0002-8222

Product Visual Gallery

This gallery contains 56 technical images submitted to the FDA as part of the official labeling for Insulin Lispro (NDC 0002-8222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Carton – Insulin Lispro Injection Junior Kwikpen (Insulin Lispro Jrkp 048 00)

Packaging label for Insulin Lispro Junior KwikPen injection, 100 units per mL (U-100) solution for subcutaneous use. The box contains five 3 mL prefilled pens designed for single patient use. Manufactured by Eli Lilly and Company, the label includes dosage information and storage instructions.*

FDA Label Image

Insulin Lispro Kp 036 03

Insulin Lispro Injection KwikPen U-100 100 units per mL prefilled insulin delivery device packaging label. The label shows a box for 5 x 3 mL prefilled pens by Eli Lilly and Company. It includes warnings, storage instructions, and notes that needles are not included. The label specifies single patient use and provides contact information for Eli Lilly.*

FDA Label Image

Package Carton – Insulin Lispro Injection 10 mL Vial 1ct (Insulin Lispro Vial 027 03)

Packaging label for Insulin Lispro Junior KwikPen, 100 units/mL injection solution by Eli Lilly and Company. The label includes dosing details, warnings about insulin use, storage instructions to refrigerate and not freeze, barcode, NDC number 0002-7737-01, and indicates the product is U-100 strength for subcutaneous injection, with a 10 mL volume.*

FDA Label Image

Primary Structure (Lispro Chem V1)

Chemical structure diagram displaying the amino acid sequences of the A-Chain and B-Chain of insulin lispro, highlighting peptide bonds and disulfide linkages between cysteine residues.*

FDA Label Image

Figure (Lispro Clock V1)

An illustration of a stopwatch displaying 5 seconds, likely indicating a recommended wait or timing instruction related to the use of the Insulin Lispro Junior KwikPen injection solution.*

FDA Label Image

Figure (Lispro Ifu Peel V1)

An instructional illustration showing a hand holding a vial and another hand holding a syringe, indicating the action of drawing medication from the vial with an arrow suggesting movement or rotation.*

FDA Label Image

Figure (Lispro Ifu Remove Shield V1)

An instructional diagram showing the proper handling of an insulin pen needle. It advises to keep the outer needle shield and to throw away the inner needle shield, illustrated with images of each shield and an arrow pointing left.*

FDA Label Image

Figure (Lispro Ifu Twist V1)

An instructional illustration showing a close-up of the tip of an Insulin Lispro Junior KwikPen injection device with a red arrow indicating the removal of a protective cap or seal from the pen needle before use.*

FDA Label Image

Figure (Lispro Inj Sites V1)

An anatomical diagram showing recommended injection sites for subcutaneous use. The front view highlights the abdomen and upper thighs, and the back view highlights the upper buttocks, indicating areas suitable for injection.*

FDA Label Image

Figure (Lispro Jr Ifu 1 V1)

Insulin Lispro Junior KwikPen is a subcutaneous injection device featuring 100 units per mL insulin lispro solution. The pen is primarily dark gray with an orange and white label indicating it is for single patient use only, labeled by Eli Lilly and Company.*

FDA Label Image

Figure (Lispro Jr Ifu 10 V1)

An illustration showing a close-up of the dose selector window on the Insulin Lispro Junior KwikPen. A red arrow points to the number 4 in the dose window, indicating the selected insulin dose in insulin units on the pen's dosage dial.*

FDA Label Image

Figure (Lispro Jr Ifu 11 V1)

An illustration showing a close-up view of the dosage selector window on an Insulin Lispro Junior KwikPen with a red arrow pointing to the dose number 11. The image highlights the dose setting mechanism for precise insulin administration.*

FDA Label Image

Figure (Lispro Jr Ifu 12 V1)

An instructional illustration showing a person preparing to inject Insulin Lispro Junior KwikPen subcutaneously into the abdomen. The image depicts hand positioning for properly administering the injection, emphasizing the injection technique for insulin solution.*

FDA Label Image

Figure (Lispro Jr Ifu 13 V1)

An illustration showing a close-up view of the dose selector window on an Insulin Lispro Junior KwikPen injection device. The window displays a dose setting, indicating the device's function for precise dose measurement in subcutaneous insulin administration.*

FDA Label Image

Figure (Lispro Jr Ifu 14 V1)

An instructional illustration showing a hand holding an Insulin Lispro Junior KwikPen injection pen. The image demonstrates removing the pen cap, indicated by a red arrow pointing away from the pen. The diagram is designed to guide proper use of the injection pen for subcutaneous administration.*

FDA Label Image

Figure (Lispro Jr Ifu 15 V1)

An instructional illustration demonstrating the twisting or turning action on the cartridge or pen device of an Insulin Lispro Junior KwikPen injection. The image shows a hand holding the pen with red arrows indicating the direction to twist the needle cap or part of the pen. No text or branding is visible in the image.*

FDA Label Image

Figure (Lispro Jr Ifu 16 V1)

An instructional illustration showing the removal of the cap from an Insulin Lispro Junior KwikPen injection pen, indicated by a red arrow pointing away from the cap toward the pen body.*

FDA Label Image

Figure (Lispro Jr Ifu 2 V1)

Illustration of the Insulin Lispro Junior KwikPen, a subcutaneous injection pen for insulin lispro 100 [iU]/mL by Eli Lilly and Company. The diagram labels parts including the pen cap with clip, rubber seal, cartridge holder, plunger, labeled pen body, dose window, dose indicator, and dose knob.*

FDA Label Image

Figure (Lispro Jr Ifu 3 V1)

An instructional illustration showing parts of a pen needle for an injection device. It depicts the outer needle shield, inner needle shield, needle, and paper tab, labeled as 'Pen Needle Parts (Needles Not Included),' alongside a separate image of a dose knob.*

FDA Label Image

Figure (Lispro Jr Ifu 4 V1)

An instructional illustration showing the proper positioning for administering a subcutaneous injection with Insulin Lispro Junior KwikPen. The image depicts the pen needle being inserted parallel to the skin with a red arrow indicating the direction for injection.*

FDA Label Image

Figure (Lispro Jr Ifu 5 V1)

An instructional diagram showing the dose window and zoomed-in view of the dosage selector on the Insulin Lispro Junior KwikPen injection device, indicating how to adjust the insulin dose by turning the dial.*

FDA Label Image

Figure (Lispro Jr Ifu 6 V1)

An instructional illustration showing hands holding an Insulin Lispro Junior KwikPen injection device. One hand holds the pen while the other hand adjusts the dose selector. The image emphasizes the proper way to set the dose before injection.*

FDA Label Image

Figure (Lispro Jr Ifu 7 V1)

An instructional illustration showing a hand holding an insulin pen with a close-up inset of a needle tip with a drop of liquid at its end, indicating proper preparation or priming of the Insulin Lispro Junior KwikPen injection before use.*

FDA Label Image

Figure (Lispro Jr Ifu 8 V1)

An illustration showing a close-up view of the dose selector window and dose knob of the Insulin Lispro Junior KwikPen injection device. The dose window displays dose increments with markings, including 0 and 0.5 units, indicating partial unit dosing.*

FDA Label Image

Figure (Lispro Jr Ifu 9 V1)

An illustration showing the dosage window and a red arrow on the dial of an insulin pen, indicating how to adjust or set the dose. The image highlights a close-up of the pen's dosage selection component, typically used for Insulin Lispro Junior KwikPen 100 IU/mL injection by Eli Lilly and Company.*

FDA Label Image

Lispro Kp Ifu 1 V3

The image shows an Insulin Lispro Junior KwikPen, a subcutaneous injection solution with 100 units per mL strength. The pen is blue and white with labeling indicating "Insulin Lispro Injection KwikPen U-100" and a note that it is for single patient use only. Manufactured by Eli Lilly and Company.*

FDA Label Image

Lispro Kp Ifu 10 V2

Illustration showing the dose window and dial of the Insulin Lispro Junior KwikPen, a subcutaneous injection device containing insulin lispro 100 units/mL, designed for pediatric insulin delivery by Eli Lilly and Company. The window displays numerical dose increments to assist in accurate dosing.*

FDA Label Image

Lispro Kp Ifu 11 V2

An instructional illustration showing a hand holding an insulin pen, with a zoomed-in view of the dose selector indicating insulin units 8 and 10. A red arrow points upward, suggesting the direction to turn the dose dial on the injection pen.*

FDA Label Image

Lispro Kp Ifu 12 V3

An illustration showing a close-up view of an insulin pen dose selector window displaying the number 12, with a red arrow pointing at the number, indicating dose selection adjustment on the Insulin Lispro Junior KwikPen.*

FDA Label Image

Lispro Kp Ifu 13 V3

Illustration of the dose selection window on an Insulin Lispro Junior KwikPen injection device by Eli Lilly and Company. The image highlights the dose display, indicating the dialed insulin units, used for accurate subcutaneous injection dosing of Insulin lispro 100 units/mL solution.*

FDA Label Image

Lispro Kp Ifu 16 V2

An instructional illustration showing the proper technique for administering a subcutaneous injection with an insulin pen device. The user holds the pen at the injection site on the abdomen, demonstrating how to position and insert the needle for insulin delivery.*

FDA Label Image

Lispro Kp Ifu 18 V2

An instructional illustration showing a hand holding an Insulin Lispro Junior KwikPen pen injector. The pen needle cap is being removed by pulling it straight off with an arrow indicating the direction of removal. The image focuses on preparing the pen for injection.*

FDA Label Image

Lispro Kp Ifu 19 V2

An instructional illustration showing a hand holding an insulin pen syringe with a cap being twisted off or removed from the pen. The pen displays measurement markings for insulin dose in insulin units. This demonstrates the initial step in preparing the Insulin Lispro Junior KwikPen for injection.*

FDA Label Image

Lispro Kp Ifu 2 V3

Illustration of the parts of an Insulin Lispro Junior KwikPen injection device by Eli Lilly and Company. It labels components including the pen cap with cap clip, rubber seal, cartridge holder with insulin cartridge markings, plunger, product label stating Insulin Lispro Injection KwikPen U-100, pen body, dose indicator with dose window, and dose knob.*

FDA Label Image

Lispro Kp Ifu 20 V3

Illustration showing the removal of the protective cap from an Insulin Lispro Junior KwikPen injection device. The pen is blue with a visible cartridge inside, and an arrow indicates the direction to pull the cap off before use.*

FDA Label Image

Figure (Lispro Kp Ifu 2a V1)

An instructional diagram showing the parts of a pen needle without the needle itself. It includes labeled components: outer needle shield, inner needle shield, needle, and paper tab. To the right, a dose knob is depicted from a top-down view.*

FDA Label Image

Lispro Kp Ifu 3 V3

An instructional illustration showing how to remove the cap from the Insulin Lispro Junior KwikPen injection pen by pulling it straight off, indicated with a red arrow pointing left. The pen is depicted in blue with a white cap, demonstrating preparation for use.*

FDA Label Image

Lispro Kp Ifu 7 V2

An instructional illustration showing a close-up of the dose selector window on an Insulin Lispro Junior KwikPen. The window displays the dose numbers 1, 2, and 4, with a red arrow pointing upward to the dial mechanism, indicating how to adjust the dose.*

FDA Label Image

Lispro Kp Ifu 8 V2

An instructional illustration showing hands adjusting a dose on an insulin pen. The image depicts the use of a dial mechanism on the pen, likely representing the dose selection for subcutaneous injection of insulin lispro, consistent with the Insulin Lispro Junior KwikPen.*

FDA Label Image

Lispro Kp Ifu 9 V2

An instructional illustration showing a hand holding an insulin pen with an arrow indicating a push action on the pen's bottom. A magnified inset highlights the pen's dial or dose window, emphasizing the mechanism for setting or delivering a dose.*

FDA Label Image

Figure 1 (Lispro Uspi 1 V2)

A line graph comparing blood glucose levels (mg/dL) over time (minutes) for Insulin Lispro Injection and Humulin R in 10 subjects each. The chart shows glucose changes following a mean dose of 15.4 units, illustrating the pharmacodynamic profiles of the two insulin formulations over an 8-hour period.*

FDA Label Image

Figure 2 (Lispro Uspi 2 V2)

A line graph comparing serum free insulin concentration (mU/L) over time (minutes) for Insulin Lispro Injection and Humulin R. Insulin Lispro shows a rapid increase and peak concentration earlier than Humulin R, which increases more gradually and peaks later. The graph includes data from 10 subjects for each insulin type with a mean dose of 15.4 U.*

FDA Label Image

Figure (Lispro Vial Ifu 1 V2)

Insulin Lispro Injection U-100 in a clear vial with a protective cap and rubber stopper under the cap. The label includes the product name Insulin Lispro Injection and strength U-100, with the Lilly logo on the vial.*

FDA Label Image

Figure (Lispro Vial Ifu 10 V1)

An instructional diagram showing the preparation of an insulin injection. The image depicts one hand holding an insulin vial upside down above a syringe, with an arrow indicating the syringes pulling fluid upward. A close-up inset shows a syringe measuring insulin units, ranging from 0 to 40 units.*

FDA Label Image

Figure (Lispro Vial Ifu 11 V1)

An instructional illustration showing a hand holding a vial and a syringe, with an arrow indicating the action of drawing liquid from the vial into the syringe. The image is black and white with simple line drawings, likely demonstrating how to prepare a subcutaneous injection.*

FDA Label Image

Figure (Lispro Vial Ifu 13 V1)

Illustration showing the administration of an insulin injection subcutaneously into the abdominal area. The image depicts a hand holding a syringe or pen device, injecting just above the waistband. An arrow indicates the direction or site of injection on the skin.*

FDA Label Image

Figure (Lispro Vial Ifu 14 V1)

An instructional illustration showing a hand administering a subcutaneous injection into the abdominal area. The image depicts the use of a syringe or pen device, inserted into the skin below the waistline, demonstrating proper injection technique.*

FDA Label Image

Figure (Lispro Vial Ifu 15 V1)

An instructional illustration showing a person using a syringe or pen injector to administer a subcutaneous injection in the upper arm area. The drawing highlights hand positioning and needle angle for injection, focusing on technique rather than product details.*

FDA Label Image

Figure (Lispro Vial Ifu 2 V2)

An instructional diagram showing the components of an insulin syringe including the needle shield, needle, plunger tip, syringe body with graduated markings, and plunger. The image highlights a sample dose of 20 units as indicated at the plunger tip within the syringe body. It provides a clear visual guide for measuring and administering insulin doses.*

FDA Label Image

Figure (Lispro Vial Ifu 3 V1)

An instructional illustration shows a hand holding an injection vial with the other hand removing the vial cap by pulling upward, demonstrating proper vial cap removal technique prior to use.*

FDA Label Image

Figure (Lispro Vial Ifu 4 V1)

An instructional illustration showing a close-up of hands preparing an injection vial. One hand holds the vial while the other hand is removing or placing a cap on the vial, demonstrating proper vial handling technique.*

FDA Label Image

Figure (Lispro Vial Ifu 5 V1)

An instructional illustration showing the preparation of an insulin injection using a syringe and vial. The image depicts a hand drawing insulin solution from a vial into a syringe, with a close-up of the syringe's graduated markings for dose measurement. The drawing emphasizes proper technique for subcutaneous injection preparation.*

FDA Label Image

Figure (Lispro Vial Ifu 6 V1)

An instructional diagram showing hands preparing an injection. One hand holds a pen injector while the other hand uses a syringe or needle to draw medication from the pen. An arrow indicates the direction of movement, suggesting proper technique for preparing the solution for injection.*

FDA Label Image

Figure (Lispro Vial Ifu 7 V1)

An instructional illustration showing hands holding an insulin pen device and needle, demonstrating the process of attaching or preparing the syringe for injection with an arrow indicating a step direction.*

FDA Label Image

Figure (Lispro Vial Ifu 8 V1)

An instructional illustration showing a hand holding an insulin syringe with an arrow pointing downward, demonstrating how to handle or prepare the syringe. To the right, a close-up image of a syringe barrel is shown with visible measurement markings indicating insulin units.*

FDA Label Image

Figure (Lispro Vial Ifu 9 V1)

An instructional illustration showing two hands preparing an injection with a syringe. One hand holds the syringe upright while the other hand stabilizes it, demonstrating proper technique for drawing or preparing insulin injection solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.